Basal Cell Carcinoma Treatment
A Sensible Basal Cell Carcinoma Treatment
Sensus Healthcare has a revolutionary basal cell treatment option with the SRT-100™.
Warm sunshine feels so good on the skin, but over your lifetime the cumulative effects of long-term sun exposure and other sources of ultraviolet light can lead to basal cell carcinoma (BCC). Nearly three million Americans are diagnosed with BCC each year—making it the most common type of all cancers. With the number of cases expected to grow, more people will undergo basal cell carcinoma treatment. Although it is the mildest form of skin cancer and rarely spreads to vital organs, rare aggressive forms of the disease can be deadly if not treated properly.
For years, traditional basal cell carcinoma treatment—including Mohs—has involved invasive cutting through healthy tissue, painful healing, lengthy recovery and unsightly scarring. Sensus Healthcare is changing all that with a basal cell treatment option with SRT. The SRT-100™ utilizes SRT (superficial radiation therapy) which kills basal cell carcinoma and squamous cell carcinoma at the source. It a few, short treatments you will be non-melanoma skin cancer free thanks to Sensus’ SRT-100™.
Now patients undergoing basal cell carcinoma treatment don’t have to worry about permanent disfigurement, nerve damage or injury to muscles due to surgery. Find more about the best basal cell treatment option by clicking the below link:
Preserve your skin’s sensual beauty.
The SRT-100™ delivers a precise, calibrated dose of Superficial Radiation Therapy (SRT) that only penetrates five millimeters below the skin’s surface. This gentle basal cell carcinoma treatment effectively destroys cancer cells without cutting, bleeding, stitching or scarring.
Performed right in the doctor’s office, basal cell carcinoma treatment with the SRT-100™ is painless. Patients usually undergo a series of treatments. The SRT-100™ delivers optimum results—a 95 plus percent cure rate for non-melanoma skin cancer. Best of all, patients don’t need reconstructive plastic surgery afterward.
The SRT-100™ can be used to remove basal cell carcinoma anywhere on the body. It works especially well on BCC located on the face, lower lip, rim of the ear, balding scalp, neck, hands, arms and legs.
- Patient Contact
- Physician Contact
-
Find an SRT-100™ physician near you
Have you been diagnosed with basal or squamous cell carcinoma and need skin cancer treatment? Do you suffer from unsightly scarring and want to find keloid removal treatment that really works? Whether you have been diagnosed with non-melanoma skin cancer or suffer from unsightly keloid scarring, the SRT-100™ offers an amazing cure rate—95 percent plus—without cutting, pain, stitching, scarring, infection or reconstructive plastic surgery.
To find an SRT provider in your area, contact us.
Sensus Healthcare
World Headquarters
851 Broken Sound Pkwy NW #215
Boca Raton FL, 33487 USAToll Free: 800-324-9890
Phone: 561-922-5808
Fax: 561-948-2071 -
-
Enhance your patient care with the SRT-100™
Sensus Healthcare provides physicians with the exceptional technology they need to perform non-invasive skin cancer treatment in Denver, along with exceptional outcomes for patients who undergo Denver keloid removal treatment. Whether you are a dermatologist, Mohs surgeon or radiation oncologist, you can enhance your treatment options with a safe and highly effective mobile SRT-100™.
To find an SRT representative in Denver, contact us.
Sensus Healthcare
World Headquarters
851 Broken Sound Pkwy NW #215
Boca Raton FL, 33487 USAToll Free: 800-324-9890
Phone: 561-922-5808
Fax: 561-948-2071 -
The Benefits of SRT
Along with eliminating the risks for post-surgical infections and complications, the SRT-100™ provides patients and physicians with a safe and effective treatment option that offers many benefits, including:
95%+ cure rates that rival surgery
No anesthesia, cutting, bleeding, stitching or pain
No downtime or lifestyle restrictions
Super cosmesis, no unsightly scarring
No need for post-treatment reconstructive surgeries